```html

Quantiferon Test Positive – Symptoms, Causes, Diagnosis & Treatment

What is Quantiferon Test Positive Symptoms?

The QuantiFERON‑TB Gold Plus (QFT‑Plus) test is a blood‑based laboratory assay that measures the immune system’s release of interferon‑γ (IFN‑γ) after exposure to specific proteins from Mycobacterium tuberculosis. A positive result indicates that the person’s T‑cells have been sensitized to TB antigens, suggesting either a latent infection or active tuberculosis (TB) disease.

Because the test itself does not cause symptoms, the phrase “Quantiferon test positive symptoms” actually refers to the clinical manifestations that may be present in a person whose immune system has reacted to TB antigens. These symptoms can range from completely absent (latent TB infection, LTBI) to the classic systemic and respiratory signs of active TB.

Sources: CDC, Tuberculosis Testing Fact Sheet; Mayo Clinic, QuantiFERON Test.

Common Causes

A positive QuantiFERON result is most often linked to exposure to Mycobacterium tuberculosis, but several other conditions can produce a similar immune response or lead to a false‑positive test. The most common causes include:

• Latent tuberculosis infection (LTBI) – bacteria are present but not causing disease.
• Active pulmonary tuberculosis – infection of the lungs, the most contagious form.
• Extrapulmonary tuberculosis – TB affecting lymph nodes, bones, meninges, genitourinary tract, etc.
• Recent conversion of the test – a new infection within the past 2‑8 weeks.
• HIV infection or other immunosuppressive states – alter immune reactivity and may give atypical results.
• Prior Bacillus Calmette‑Guérin (BCG) vaccination – generally does not affect QuantiFERON, but rare cross‑reactivity reported.
• Non‑tuberculous mycobacterial (NTM) exposure – organisms such as M. kansasii can occasionally stimulate IFN‑γ release.
• Recent viral infections (e.g., COVID‑19, influenza) – can cause temporary immune activation.
• Autoimmune diseases (e.g., sarcoidosis) – may produce false‑positive interferon‑γ responses.
• Technical issues with the assay – improper blood handling, hemolysis, or lab error.

Associated Symptoms

Whether a person experiences symptoms depends on whether TB is latent or active, and on the organ system involved.

Latent TB (usually asymptomatic)

• No cough, fever, or weight loss.
• Normal chest radiograph (sometimes a small scar).

Active Pulmonary TB

• Persistent cough lasting >3 weeks.
• Blood‑tinged sputum or hemoptysis.
• Night sweats.
• Unexplained weight loss.
• Low‑grade fever and chills.
• Fatigue and loss of appetite.
• Chest pain that may worsen with deep breathing.

Extrapulmonary TB

• Lymph node TB: painless, enlarging neck or supraclavicular nodes.
• Spinal (Pott) disease: back pain, spinal deformity, neurologic deficits.
• Meningeal TB: severe headache, neck stiffness, altered mental status.
• Genitourinary TB: dysuria, frequency, hematuria, infertility.
• Peritoneal TB: abdominal pain, ascites, low‑grade fever.

When to See a Doctor

A positive QuantiFERON test alone is not an emergency, but you should seek medical evaluation promptly if you notice any of the following:

• Cough lasting more than three weeks, especially with sputum or blood.
• Unexplained fever, night sweats, or weight loss.
• Painful or enlarging lymph nodes.
• Persistent chest pain or shortness of breath.
• Neurologic symptoms such as severe headache, confusion, or weakness.
• Back pain that does not improve or is accompanied by numbness.
• Any symptoms that worsen despite over‑the‑counter treatment.

Early evaluation can differentiate latent infection from active disease and prevent transmission.

Diagnosis

After a positive QuantiFERON test, clinicians follow a systematic approach:

1. Clinical history and risk assessment – travel to endemic areas, known exposure, immunocompromise.
2. Physical examination – focus on lungs, lymph nodes, spine, and neurological signs.
3. Chest radiograph (CXR) – looks for infiltrates, cavitation, or old fibrotic scars.
4. Sputum analysis (if pulmonary symptoms)
   • Three early‑morning sputum samples for acid‑fast bacilli (AFB) smear.
   • Culture on solid (Löwenstein‑Jensen) and liquid (MGIT) media – gold standard.
   • Nucleic acid amplification test (NAAT) for rapid detection of M. tuberculosis DNA.
5. Additional imaging – CT of chest, MRI of spine or brain when extrapulmonary disease is suspected.
6. Biopsy & histopathology – for lymph node, bone, or meningitis cases; look for caseating granulomas and AFB.
7. Drug‑susceptibility testing (DST) – performed on cultured isolates to guide therapy.

Guidelines from the World Health Organization (WHO) and the American Thoracic Society (ATS) recommend using a combination of these tools to confirm active disease.

Treatment Options

Treatment depends on whether infection is latent or active, the site of disease, and drug‑resistance patterns.

Latent TB Infection (LTBI)

• Isoniazid (INH) monotherapy: 300 mg daily for 6–9 months.
• Rifampin (RIF) monotherapy: 600 mg daily for 4 months (alternative for INH intolerance).
• Combination INH + Rifapentine (3HP): once‑weekly dose for 12 weeks – preferred for many adults.
• All regimens require baseline liver‑function tests and monitoring for toxicity.

Active TB (Drug‑Sensitive)

1. Intensive phase (2 months): Isoniazid + Rifampin + Pyrazinamide + Ethambutol (HRZE) daily or thrice‑weekly.
2. Continuation phase (4‑7 months): Isoniazid + Rifampin (HR) daily or thrice‑weekly.

Directly observed therapy (DOT) is recommended to ensure adherence.

Drug‑Resistant TB

• Multidrug‑resistant (MDR‑TB) requires at least 4–5 effective second‑line agents for 18‑24 months.
• Newer drugs such as bedaquiline and delamanid are included in WHO‑approved regimens.
• Management should be coordinated with a TB specialist or public‑health program.

Supportive & Home Care Measures

• Take medications exactly as prescribed; never stop early.
• Maintain good nutrition – protein‑rich diet, adequate calories.
• Avoid alcohol and hepatotoxic drugs while on INH or RIF.
• Monitor for side‑effects: rash, visual changes, jaundice, neuropathy.
• Use a mask if you have active pulmonary TB to reduce transmission.

Prevention Tips

• Vaccination: Bacillus Calmette‑Guérin (BCG) in high‑risk countries reduces severe childhood TB.
• Screen high‑risk groups: Recent contacts, healthcare workers, HIV‑positive individuals, migrants from endemic regions.
• Infection control: Proper ventilation, UV germicidal lights in healthcare settings, and airborne‑precaution masks for suspected cases.
• Prompt treatment of LTBI: Reduces the risk of progression to active disease by up to 90 %.
• Healthy lifestyle: Adequate sleep, balanced diet, and avoidance of tobacco and excessive alcohol lower susceptibility.
• Travel precautions: If visiting high‑TB prevalence areas, avoid close, prolonged exposure to people with coughs; consider screening after return.

Emergency Warning Signs

Understanding what a positive QuantiFERON test means and recognizing accompanying symptoms are essential steps toward timely diagnosis and effective treatment. If you have a positive result, work closely with your healthcare provider to determine whether you have latent infection or active disease, and follow the recommended therapy to protect your health and that of those around you.

---

References:

1. Centers for Disease Control and Prevention. Tuberculosis (TB) Testing. 2023. https://www.cdc.gov/tb/publications/factsheets/testing.htm
2. Mayo Clinic. QuantiFERON-TB Gold Test. 2022. https://www.mayoclinic.org/tests-procedures/quantiFERON-test/about/pac-20384799
3. World Health Organization. Guidelines for Treatment of Drug‑Resistant Tuberculosis. 2023.
4. American Thoracic Society, Infectious Diseases Society of America, CDC. Management of Tuberculosis in Adults. Clin Infect Dis. 2022.
5. Cleveland Clinic. Latent Tuberculosis Infection (LTBI). 2023.

```